Trial Profile
Comparative Study of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After Transurethral Resection of the Prostate - A Randomized Prospective Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Jan 2021
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary) ; Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 22 Nov 2020 Results presented at the 50th Annual Meeting of the International Continence Society
- 23 Aug 2018 New trial record